Lewis Capaldi's Tourette's interrupted his performance. The crowd helped him finish
The musician was coming off of a short break from touring to address health concerns. The fans at Glastonbury supported him through every note.
Health & Safety
Intermittent fasting may be equally as effective for weight loss as counting calories
When trying to lose weight, patients are often counseled to count calories, but this can be cumbersome and hard to stick with. New research finds that intermittent fasting can be just as effective.
An Alzheimer's drug could soon be approved, but accessing it may still be difficult
The Food and Drug Administration may soon grant full approval to an Alzheimer's drug. When it does, Medicare will start more widely covering the costly drug — but hurdles to access remain.
With $1.5 billion from opioid settlements, NC counties tasked with reversing epidemic
Since the start of the opioid epidemic, 3 million Americans have suffered with opioid use disorder in the United States.
How careers in public service taught one couple to fight to cure ALS
NPR's Juana Summers tracks the advocacy efforts of husband and wife Brian Wallach and Sandra Abrevaya as they try and change the landscape for ALS patients.
Without paid family leave, teachers stockpile sick days and aim for summer babies
Less than one-fifth the largest school districts offer paid parental leave for teachers, and only a handful of states guarantee it. That leaves few options for educators who want to start a family.
'We're not doing that': A Black couple won't crowdfund to pay medical debt
Kristie Fields, a cancer patient in Virginia was urged to go public to seek help for her medical bills. But she worried about feeding hurtful stereotypes.
An Alzheimer's drug is on the way, but getting it may still be tough. Here's why
The Food and Drug Administration is expected to grant full approval to the Alzheimer's drug lecanemab by July 6. But access to the drug may still be limited.
What does an older population mean for the economy, society at large?
By the year 2040, nearly half of the U.S. population will be 40 years old. NPR's Steve Inskeep talks to economist Nicole Maestas of Harvard Medical School about why that number matters.
U.S. pedestrian deaths reach a 40-year high
The number of pedestrians killed by drivers has been climbing for over a decade. Experts say some solutions are within reach.